Turning Point Brands draws coverage from a relatively small group of sell-side analysts, and their targets have shifted noticeably as the stock's performance has evolved. I reviewed five current, attributable targets: Oppenheimer (Ian Zaffino) at $90, cut from $130 in September 2026; Alliance Global Partners at $115; BTIG at $116; Needham (Gerald Pascarelli) at $125, following a May 2026 upgrade from Hold to Buy; and Roth MKM (Nick Anderson) at $125, reiterated in early November 2026. The arithmetic mean of these five targets comes to about $114, which rounds to a $115 central target. The range remains unusually wide—from $90 to $125—and some aggregators include a sixth, higher estimate near $140 that lifts a broader average toward roughly $118. All five firms maintain Buy or Outperform ratings, an unusually unanimous stance that reflects confidence in the nicotine pouch category. Yet the spread signals differing views on whether profitability can keep pace with revenue growth. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
As of the most recent close, Turning Point Brands traded at $65.88, with a 52-week range of $54.17 to $146.90. The stock sits down roughly 55% from its all-time high after a strong run followed by an unwind. Reaching the $115 average analyst price target from here implies about 75% upside, which represents a very large move by any standard. That path would require the company to sustain strong Modern Oral momentum while convincing investors that profit margins, which have come under pressure, can recover. The stock's roughly 29x trailing P/E and elevated forward multiple leave little room for execution missteps.
The primary driver remains the nicotine pouch business. In the third quarter of 2026, Modern Oral net sales rose about 103% year over year and reached roughly 49% of total revenue, up from 31% a year earlier. Management reaffirmed full-year 2026 Modern Oral net sales guidance of $260–$270 million and expects chain-store count to grow more than 70% during the year. Planned U.S. manufacturing in 2027 is also aimed at improving long-term margins. Continued distribution gains, category growth, and margin recovery are the clearest pathways supporting a higher stock price target.
The stock's decline from $146.90 highlights the risks. A second-quarter 2026 earnings miss—EPS of $0.23 versus roughly $0.43 expected—underscored profitability challenges from heavy investment in distribution and sales. Valuation has also compressed, and the elevated multiple versus the broader tobacco group leaves the shares vulnerable if growth slows. Regulatory risk around nicotine pouches, competitive pressure in a fast-growing but crowded category, and execution risk in scaling two brands simultaneously are all material obstacles.
The shares found support near the 52-week low of $54.17 in early October and have since rebounded toward the $66–$69 zone. That recent recovery high near $69 serves as near-term resistance, with the round-number $100 level standing as a larger psychological hurdle on any sustained move higher. A durable break below roughly $54 would signal renewed downside pressure.
Analyst price targets generally reflect a research horizon of about 12 months, though individual assumptions vary. Investors should watch quarterly earnings and Modern Oral guidance, chain-store distribution updates, margin trends as U.S. manufacturing scales, and any regulatory developments on nicotine pouches. Analyst revisions—which have already moved targets both up and down in 2026—will remain a key signal of shifting expectations.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile name like TPB, these signals can help traders spot shifts in momentum and manage positions more efficiently. I find them useful for staying on top of names where fundamentals and sentiment can move quickly.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Oscillator for TPB moved out of oversold territory on October 14, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 25 of the 31 cases the stock moved higher. This puts the odds of a move higher at 81%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on TPB as a result. In 55 of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for TPB just turned positive on October 07, 2026. Looking at past instances where TPB's MACD turned positive, the stock continued to rise in 28 of 40 cases over the following month. The odds of a continued upward trend are 70%.
TPB moved above its 50-day moving average on November 03, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for TPB crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 59%.
Following a +5.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where TPB advanced for three days, in 231 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 56 cases where TPB's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TPB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
TPB broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TPB entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. TPB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.071) is normal, around the industry mean (-7.297). P/E Ratio (28.154) is within average values for comparable stocks, (12.512). Projected Growth (PEG Ratio) (0.048) is also within normal values, averaging (3.595). Dividend Yield (0.005) settles around the average of (0.060) among similar stocks. P/S Ratio (2.701) is also within normal values, averaging (2.780).
The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TPB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of tobacco products
Industry Tobacco